Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update
Status as of 14.04.2021
In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.
Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.
The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The goods are usually allocated and information provided on their respective availability by the department at the Federal Office of Public Health responsible for procuring medical goods.
Distribution period ongoing
Active substance |
Pharmaceutical form / Dosage |
Batch reference |
Distribution licensed until |
Propofol |
Emulsion for injection |
K20001A K20005A K20005B |
31.12.2022 |
Remifentanil |
Powder for preparation of a solution for infusion, 5 mg |
50PEH013 |
30.04.2022 |
Remifentanil |
Powder for preparation of a solution for infusion, 1 mg |
50PDH010 |
30.04.2022 |
Propofol |
Emulsion for infusion 2 % MCT |
16PD7549 |
31.12.2021 |
Propofol |
20 mg/ml (50 ml emulsion for injection in a pre-filled syringe) |
RM659 |
31.12.2021 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.005mg/ml (10x10 ml) |
KY3H R49N |
31.12.2021 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.05mg/ml (10x5 ml) |
9D7B |
31.12.2021 |
Remdesivir |
Powder for preparation of a solution for infusion, 100 mg |
C2000141D2 20410871D1 00009D 00009D4 00010D2 20411011M AP0083BM1 AP0425BM1 |
25.11.2022 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.005mg/ml (5 x 2 ml) |
MU9A |
29.10.2021 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.005mg/ml (10 x 10 ml) |
JG9W |
29.10.2021 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.05 mg/ml (10 x 5 ml) |
HG2B |
29.10.2021 |
Sufentanil / Sufentanil citrate |
Solution for injection, 0.005 mg/ml (5 x 10 ml) |
BG4B |
29.10.2021 |
Propofol |
Emulsion for injection/infusion, 10 mg/ml |
20K001A 20K001B 20K002A 20K002B 20K003A 20K003B |
31.08.2021 |
Haemagglutininum influenzae A (H1N1) (H3N2) Haemagglutininum influenzae B (Victoria) (Yamagata) |
Suspension for injection |
X47 |
30.06.2021 |
Voriconazol |
Powder for preparation of a solution for infusion, 200 mg |
6452099 |
30.06.2021 |
Dexamethasone |
Tablets, 4 mg |
285120C |
30.06.2021 |
Haemagglutininum influenzae A (H1N1) Haemagglutininum influenzae A (H3N2) Haemagglutininum influenzae B |
Suspension for injection |
7132B1A |
30.04.2021 |
Distribution period elapsed: products may still be present at the dispensing outlets; dispensing and use permitted until the batches have expired
Active substance |
Pharmaceutical form / Dosage |
Batch reference |
Distribution licensed until |
Rocuronium |
Solution for injection 50 mg/5 ml |
T012764 |
31.01.2021 |
Hydroxychloroquine |
Lactab, 200mg |
IYZ019 001- IYZ019 007 |
31.12.2020 |
Propofol |
Emulsion for injection/infusion, 10 mg/ml |
V19A013A V19A013B V19A013C |
31.12.2020 |
Lopinavir / Ritonavir |
Film-coated tablets, 200 mg/tab. and 50 mg/tab. |
1125683 1125601 1126558 |
31.12.2020 |
Lopinavir / Ritonavir |
Syrup, 400 mg/5 ml and 100 mg/5 ml |
6088208 6088549 |
31.12.2020 |
Rocuronium |
Solution for injection 50 mg/5 ml |
T007003 |
31.12.2020 |
Propofol |
Emulsion for injection and infusion, 10 mg/ml |
10PC9969 16PB6740 |
31.12.2020 |
Hydroxychloroquine |
Film-coated tablets, 200 mg |
JM2447 |
31.12.2020 |
Lopinavir / Ritonavir |
Tablets, 200 mg/50 mg |
E200320 |
31.12.2020 |
Midazolam |
Ampoules, 50 mg/10 ml |
F1038F08 F1048F02 |
31.12.2020 |
Midazolam |
Ampoules, 50 mg/10 ml |
F1058F02 |
31.12.2020 |
Atazanavir |
Capsules, 200 mg |
ABH6626 |
30.11.2020 |
Amoxicillin / Clavulanic acid |
2g/200 mg, powder for preparation of a solution for injection or infusion |
KS3429 |
30.11.2020 |
Posaconazole |
Gastro-resistant tablet, 100 mg |
T001796 T001390 |
01.11.2020 |
Amoxicillin / Clavulanic acid |
2g/200 mg, powder for preparation of a solution for injection or infusion |
KS3426 KS3427 |
30.10.2020 |
Amoxicillin / Clavulanic acid |
2g/200 mg, powder for preparation of a solution for injection or infusion |
KP0957 |
31.08.2020 |
Budesonide / Formoterol |
Powder for inhalation, 100 µg/6 µg |
LATU |
31.08.2020 |
Budesonide / Formoterol |
Powder for inhalation, 100 µg/6 µg |
SLGV |
31.08.2020 |
Erythromycin |
Powder for solution for infusion, 1 g |
01124TB23 |
31.07.2020 |
Solution for haemodialysis and haemofiltration |
Sodium 140 mmol/l Potassium 4 mmol/l Magnesium 0.75 mmol/l Chloride 122 mmol/l Hydrogen phosphate 1 mmol/l Hydrogen carbonate 22 mmol/l / 1000 ml |
19G0415 19K0610 |
30.06.2020 |